The Ambifect version of the new trial drug builds on Akston's anti-cPD-L1 mAb, designed to target and block the cPD-L1 protein on cancer cells, which is currently in clinical trial for dogs with ...

Akston, the Biotech Built for Pets, in partnership with Purdue University and its College of Veterinary Medicine, announced today that it has initiated a clinical study to evaluate a first–in–class ...

Mast cell tumors are prevalent skin neoplasms observed in veterinary clinical practice, particularly affecting both dogs and cats. Over the years, rigorous ...

The younger a dog is when it is spayed or neutered, the more likely it is to develop negative health conditions later in life ...

A: A mast cell tumor, or MCT, is the most common form of skin cancer in dogs. Mast cells are white blood cells designed to fight parasites and allergies. It's not clear why some of these immune cells ...

The most common treatment is surgical removal of the MCT, which is often curative, especially for low-grade tumors that are ...

Mast cell tumors (MCTs) are among the most common skin cancers affecting dogs and cats. These tumors originate from mast cells – immune cells that play a key role in allergic reactions and ...

Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...

The older Australian shepherd warned the puppy he was done playing. Lawmakers Raise Alarms on Taxpayer-Funded Aid National Weather Service at ‘breaking point’ as storm approaches Thieves steal $1M ...

INDIANAPOLIS — New research by the IU School of Medicine is looking at new ways to fight aggressive cancers. Right now the focus is on enhancing treatment options for aggressive cancers like triple ...

LOUISVILLE, Ky. (WDRB) -- Researchers at the Indiana University School of Medicine are developing new ways to fight tumors and aggressive forms of cancer—such as triple-negative breast cancer, ...